Vaccine makers give India shot in the arm

Using private-public partnerships, firms climb up the value chain

Joe Matthew New Delhi

A few days earlier, clinical trial investigators in Pune, Vellore and Delhi completed vaccinating 6,800 infants with Rotavac, an experimental rotavirus vaccine being developed by Hyderabad-based Bhara

Also Read

Indian equities back in the reckoning

Cues for successful MF investing

NBCC IPO subscribed five times

<B>BS People:</B> Bo Shin Seo

Tata Motors: Competitive pressures to increase

Natco formulates a new opportunity

<b>BS People:</b> R Dinesh

Chavan bats for 'innovation economy'

High margin, growth prescription for Strides Arcolab

Why private equity loves the Shriram Group

Natco formulates a new opportunity

First Published: Mar 28 2012 | 12:25 AM IST

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to